| Growth differentiation factor 15: An additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects? | |
| | |
MedLine Citation:
|
PMID: 21742099 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Many young adults who have congenital heart defects develop heart failure despite corrective surgeries. Growth differentiation factor 15 (GDF-15) has an established role as a marker for risk stratification and mortality both in patients after acute myocardial infarction and in patients with heart failure. Our aim was to establish a role for GDF-15 for monitoring heart failure in operated congenital heart defects (ACHD). This potential biomarker was validated through comparison with maximal oxygen uptake (VO(2max)) and to another biomarker, N-terminal pro-brain natriuretic peptide (NT-proBNP). METHODS: A total of 317 ACHD patients (129 females) with an average age of 26.5 ± 8.5 years (mean ± SD) enrolled in the study. We studied the relation between GDF-15 and NT-proBNP and VO(2max%) (percent predicted for age and gender). The cutoffs for the groups were as follows: NT-proBNP <100, 100 to 300, and >300 pg/mL; VO(2max%) <65%, 65% to 85%, and >85% of predicted normal. RESULTS: Significant differences in mean GDF-15 levels were found between the NT-proBNP <100 and NT-proBNP >300 groups, as well as between the 100 to 300 and the >300 groups. For VO(2max%), significant differences were found in GDF-15 levels between <65% and >85% and between <65% and 65% to 85%, respectively. The lowest mean GDF-15 was found in groups with NT-proBNP <100 pg/mL and VO(2max%) >85%. The highest mean GDF-15 was found in the groups with NT-proBNP >300 pg/mL and VO(2max%) <65%. A subgroup analysis, including 82 patients with operated tetralogy of Fallot, showed that patients in the New York Heart Association I class have significantly lower NT-proBNP and GDF-15 level and markedly higher VO(2max) compared with the patients in higher New York Heart Association class. CONCLUSION: Growth differentiation factor 15 might be used as a surrogate marker for latent heart failure and could help to identify patients with ACHD who are at risk for developing heart failure, even if they are clinically asymptomatic. |
| | |
Authors:
|
Kambiz Norozi; Reiner Buchhorn; Abeer Yasin; Siegfried Geyer; Lutz Binder; Jamie A Seabrook; Armin Wessel |
Related Documents
:
|
22411359 - Cost-effectiveness of cytochrome p450 2c19 genotype screening for selection of antiplat... 22904109 - Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabet... 9731689 - Left ventricular dilatation after myocardial infarction: ace inhibitors, beta-blockers,... 21604919 - Endothelial dysfunction predicts clinical restenosis after percutaneous coronary interv... 6108879 - A case report of maternal death associated with betamimetics and betamethasone administ... 8576789 - Update on the use of angiotensin converting enzyme inhibitors and calcium antagonists i... 7977819 - Activation of atp-sensitive potassium channels lowers threshold for ischemic preconditi... 23315159 - An 8-year single-centre experience of cardiac resynchronisation therapy: procedural suc... 19185649 - Predictive factors for in-stent late loss and coronary lesion progression in patients w... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: American heart journal Volume: 162 ISSN: 1097-6744 ISO Abbreviation: Am. Heart J. Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-07-11 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: United States |
Other Details:
|
Languages: eng Pagination: 131-5 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2011 Mosby, Inc. All rights reserved. |
Affiliation:
|
Department of Paediatrics, London Health Sciences Centre, University of Western Ontario, Canada; Departments of Paediatric Cardiology and Intensive Care Medicine, Medical School, Hannover, Germany; Children's Health Research Institute, London, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan c...
Next Document: Resting cardiac energy metabolism is inversely associated with heart rate in healthy young adult men...